Profiel
Richard A. Morgan is currently the Director at the American Society of Gene & Cell Therapy.
Prior to this, he was the Senior Vice President-Immunogenetics at Editas Medicine, Inc. from 2018 to 2021.
He received his undergraduate degree from Brandeis University and his doctorate from The Johns Hopkins University.
Actieve functies van Richard A. Morgan
| Bedrijven | Functie | Begin |
|---|---|---|
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services Operates as medical and professional organization that represents researchers and scientists devoted to the discovery | Directeur/Bestuurslid | - |
Eerdere bekende functies van Richard A. Morgan
| Bedrijven | Functie | Einde |
|---|---|---|
| EDITAS MEDICINE, INC. | Corporate Officer/Principal | 01-02-2021 |
Opleiding van Richard A. Morgan
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Brandeis University
Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Editas Medicine, Inc.
Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services Operates as medical and professional organization that represents researchers and scientists devoted to the discovery | Commercial Services |
















